Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Kewaunee Scientific ( (KEQU) ) is now available.
On June 11, 2025, Kewaunee Scientific Corporation announced its plan to release the financial results for its fourth quarter and fiscal year ending April 30, 2025, on June 25, 2025, after market close. The announcement is significant for stakeholders as it provides insights into the company’s financial performance and strategic direction, especially following its acquisition of Nu Aire, which is expected to bolster its market position in laboratory and healthcare furniture products.
Spark’s Take on KEQU Stock
According to Spark, TipRanks’ AI Analyst, KEQU is a Outperform.
Kewaunee Scientific’s robust financial performance, despite cash flow challenges, and attractive valuation contribute significantly to its overall score. Positive technical indicators further enhance the stock’s appeal. However, cash flow management remains a key area for improvement to ensure long-term growth.
To see Spark’s full report on KEQU stock, click here.
More about Kewaunee Scientific
Kewaunee Scientific Corporation, founded in 1906, is a global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, including steel and wood casework, fume hoods, and biological safety cabinets. The company operates from its headquarters in Statesville, North Carolina, with additional sales offices in the United States, India, Saudi Arabia, and Singapore, and manufacturing facilities in Statesville and Bangalore, India. Its subsidiary, Nu Aire, enhances its portfolio with products like biological safety cabinets and CO2 incubators.
Average Trading Volume: 17,514
Technical Sentiment Signal: Buy
Current Market Cap: $112.7M
For detailed information about KEQU stock, go to TipRanks’ Stock Analysis page.